Vaccine beneficiaries, according to the government, have the option to access more information about the vaccine and its adverse events. In...

"Your lordships are aware, all of you are vaccinated, but got infected again in Omicron. There are many people who I know who got infected ...

The FAA has been in talks with airplane makers, airlines and wireless carriers to reduce the impact of new wireless service set to begin on...

As mutual funds flooded the market with niche new products in the past six months, retail investors have shown appetite for them. The deman...

Markets would be keen to see if some unconventional or untested measures are likely to be taken as we ruminate over an extended pause.

Drugs under clinical trials in other countries can be brought to India to treat life-threatening diseases, but prohibitive cost remains a w...

While the mothers waited for guidelines, seven of the 34 children chosen for compassionate use of the new drug, Risdiplam, passed away. “It...

The ministry of health and family welfare is amending the New Drugs and Clinical Trials Rules 2019, enabling any government or private hosp...

Health officials in Mumbai said that a test to prove the efficacy of the much touted but largely untested drug was still in the cards, but ...

In the absence of credible evidence, a blanket recommendation for chemoprophylaxis might be contentious, the experts said in an article pub...

Kumar was replying to a query on Trump's policy of protectionism at a news conference to announce the "Indian Pharma" conference.

The launch of its instant noodle brand mysteriously coincided with a ban (now lifted) on Swiss MNC Maggi’s 2-Minute Noodles, the market lea...

A case in point is a life-saving drug, Liposomal Amphotericin B, which is used to treat fungal infections in critically-ill patients.

Sources in the Health Ministry admit that as many as 26 new drug molecules have been approved since 2010 without testing them.

The Supreme Court today expressed concern over the alleged ongoing illegal clinical trial of untested drugs in the country and said the gov...

The Supreme Court today sought the Centre's response on a PIL seeking inquiry into alleged illegal clinical trials of untested drugs.

The report says the Congress party has three options for breaking the leadership logjam. The party can maintain the status quo, but it woul...